Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: CLOZAPINE Response in Biotype-1 [Phase 4]
Phase 4 clinical trial evaluating Clozapine response in Biotype-1 is currently recruiting at UT Southwestern, studying schizophrenia, schizo…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients [Phase 3]
A Phase 3 clinical trial is evaluating whether adding empagliflozin, an SGLT2 inhibitor, can mitigate metabolic disturbances associated with…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Validation of a Scale to Evaluate the Perception of Oral Health in Patients With Schizophrenia [NA]
A completed study validating a scale to evaluate perceived oral health in patients with schizophrenia.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations [NA]
Active-not-recruiting clinical trial evaluating Neuro-VR therapy augmented with biofeedback for auditory hallucinations in schizophrenia at …
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Study of SPG302 in Adults With Schizophrenia [Phase 2]
This is a Phase 2 clinical trial update for SPG302 in adults with schizophrenia; the study is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia [Phase 3]
Open-label Phase 3 study assessing safety and tolerability of flexible-dose brexpiprazole as maintenance treatment in adolescents with schiz…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Carbergoline for Antipsychotic Induced Hyperprolactinemia. [Phase 4]
Phase 4 clinical trial update investigating carbergoline for antipsychotic-induced hyperprolactinemia in schizophrenia, currently not yet re…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Illness Management and Recovery (IMR) in Danish Community Mental Health Centres [NA]
A completed clinical trial evaluating Illness Management and Recovery (IMR) in Danish community mental health centres, sponsored by Amager H…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients [NA]
Clinical trial update reports that transcranial random noise stimulation (tRNS) targeting the anterior cingulate cortex reduced cravings in …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial [NA]
A clinical trial evaluating maintenance electroconvulsive therapy for clozapine-resistant schizophrenia, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Inter-Brain Synchrony in Schizophrenia [NA]
A clinical trial at University of California, Los Angeles is currently recruiting to study inter-brain synchrony in schizophrenia.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Magnetic Seizure Therapy for Schizophrenia - Trial [NA]
Clinical trial evaluating Magnetic Seizure Therapy for schizophrenia-related conditions is currently recruiting, sponsored by the Centre for…
-
CLINICAL_TRIALS other · 2026-02-03Clinical Trial Update: Enhancing Recovery in Early Schizophrenia [Phase 2]
A Phase 2 clinical trial in schizophrenia sponsored by the Central Institute of Mental Health Mannheim is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES) [NA]
The PACES trial at the University of Pittsburgh is currently recruiting to test promoting activity and cognitive enrichment in individuals w…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? [NA]
A clinical trial from the University of Nottingham is evaluating the feasibility of Narrative Exposure Therapy for people experiencing psych…
-
FDA approval · 2026-01-30FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company.
-
FDA approval · 2026-01-30FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2026-01-30FDA Approved: LYBALVI — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for LYBALVI (olanzapine and samidorphan L-malate) from Alkermes, Inc., resulting in labeling cha…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Enhancing Rehabilitation for Veterans With Serious Mental Illness [NA]
A VA-sponsored clinical trial aims to enhance rehabilitation for veterans with serious mental illness and related conditions. It is currentl…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Clay Therapy in Schizophrenia Patients [NA]
A clinical trial is investigating clay therapy as an intervention for schizophrenia, sponsored by Kutahya Health Sciences University, with r…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Impact of Medication Education on Adherence and Side Effects [NA]
A clinical trial update from Cumhuriyet University studying whether medication education improves adherence and reduces side effects in schi…
-
FDA approval · 2026-01-28FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole) from Otsuka America Pharmaceutical, indicating a modification to…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Zyprexa® Relprevv™ Patient Care Program
Eli Lilly provides an update on the Zyprexa Relprevv patient care program for schizophrenia, with enrollment ongoing by invitation.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: SV2 PET Imaging With [11C]APP311
Clinical trial update on SV2 PET imaging with the radioligand [11C]APP311. The study is currently recruiting participants for schizophrenia,…
-
CLINICAL_TRIALS withdrawal · 2026-01-28Clinical Trial Update: Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department [Phase 4]
A Phase 4 pilot trial of BXCL501 (sublingual dexmedetomidine) for agitation in the emergency department, including schizophrenia-spectrum an…